Arteris, Inc.·4

Mar 4, 6:10 PM ET

RAZA SAIYED ATIQ 4

4 · Arteris, Inc. · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-02
Transactions
  • Sale

    Common Stock

    [F1][F2][F3]
    2026-03-02$17.21/sh106,031$1,825,080393,690 total(indirect: By Trust)
  • Sale

    Common Stock

    [F1][F4][F3]
    2026-03-04$17.02/sh3,690$62,786390,000 total(indirect: By Trust)
Holdings
  • Common Stock

    20,839
Footnotes (4)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
  • [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza|2026-03-04

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT